Cancer News
OncoLink Cancer News - HealthDay


Surgeon Error Linked to Skin Tumor Recurrence

Thursday, June 20, 2013 (Last Updated: 06/21/2013)

THURSDAY, June 20 (HealthDay News) -- Errors in surgeons' interpretation of histological slides are strongly associated with tumor recurrence after Mohs micrographic surgery (MMS), according to a study published in the July issue of the Journal of the American Academy of Dermatology.

Tracy Campbell, M.D., from Chicago Cosmetic Dermatology and Surgery, and colleagues examined the association between slide characteristics and surgeon error and tumor recurrence in 19 cases of cancer that recurred after MMS and 95 control cases that were treated with MMS without recurrence.

After controlling for various factors, the researchers found that surgeon error, tissue drop out, and aggressive tumor subtype were significant factors associated with tumor recurrence.

"The results of our study suggest that surgeon interpretation errors, tissue drop out, and aggressive tumor type are the primary factors resulting in recurrences after MMS," Campbell and colleagues conclude. "Two of these factors are within the control of the treating physician, and thus potentially improvable."

Abstract
Full Text (subscription or payment may be required)

Specialties Dermatology
Surgery
Hematology & Oncology

Health News Copyright © 2013 HealthDay. All rights reserved.


I Wish You Knew

Making treatment decisions is difficult and you can ask for help

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More